(IN BRIEF) Boehringer Ingelheim has launched VETMEDIN® Solution, the first FDA-approved liquid treatment for congestive heart failure (CHF) in dogs caused by myxomatous mitral valve disease (MMVD) or ...
According to this new report, the global cardiac biomarkers testing market is estimated to be valued at US$ 5.7 billion in the year 2028, growing at a CAGR of 8.5% in the period 2020 to 2028. Growth ...